FLT-PET/CT

DIAGNOSTIC_TEST3 trials

Sponsors

Department of Diagnostic Radiology,Medical Hospital Tokyo Medical and Dental University, Abramson Cancer Center at Penn Medicine, Jonsson Comprehensive Cancer Center

Conditions

Adult Women With a New Diagnosis of Invasive Breast Cancer (Have Not Undergone Treatment)Large B Cell Diffuse LymphomaLymphomaLymphoma, Non-Hodgkinmalignant tumors

Unknown Phase

Positron Emission Tomography in Monitoring Treatment Response in Women With Newly Diagnosed Breast Cancer

WithdrawnNCT01018251

Abramson Cancer Center at Penn MedicineAdult Women With a New Diagnosis of Invasive Breast Cancer (Have Not Undergone Treatment)

Start: 2009-03-31End: 2011-06-30Updated: 2015-12-15

FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma

CompletedNCT01410630

Jonsson Comprehensive Cancer CenterLarge B Cell Diffuse Lymphoma, Lymphoma, Lymphoma, Non-Hodgkin

Start: 2017-09-07End: 2019-10-04Updated: 2021-05-11

study on [F-18] FDG and [F-18] FLT in the assessment of malignant tumors

Active, not recruitingJPRN-UMIN000029524

Department of Diagnostic Radiology,Medical Hospital Tokyo Medical and Dental Universitymalignant tumors

Start: 2017-11-01Target: 120Updated: 2025-07-18